Catalyst Event
Moderna Inc (MRNA) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
8/5/2026, 12:00:00 AM
The U.S. FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of August 5, 2026, for a decision on Moderna's seasonal flu vaccine, mRNA-1010; a regulatory decision on a key pipeline product is a high-impact catalyst likely to cause ≥10% price impact, scheduled.
Korean Translation
2026년 8월 5일 FDA가 독감 백신(mRNA-1010) 승인 여부를 결정할 예정임. 주요 제품의 규제 승인 결정은 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Kinder Morgan Inc. (KMI) · Other
James Holland, Chief Operating Officer, is set to retire, effective September 4, 2026. Ken Grubb, currently VP and Chief Project Officer, will succeed him as COO. The transition was announced on April 22, 2026. Impact is estimated at 1% due to the planned nature of the succession scheduled.
9/4/2026, 12:00:00 AM
HEICO Corp (HEI) · Earnings Release
Q3 2026 earnings release on 2026-08-24 scheduled.
8/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Q2 FY2027 earnings release scheduled; medium impact from financial updates expected.
8/20/2026, 12:00:00 AM
Target Corp (TGT) · Earnings Release
Q2 2026 earnings release on August 19, 2026, with analysts forecasting an EPS of approximately $2.21-$2.25; low impact estimated as the market typically prices in consensus expectations prior to the release expected.
8/19/2026, 12:00:00 AM
CoreWeave Inc (CRWV) · Earnings Release
Q2 2026 earnings release for August 18, 2026, is of high importance as such releases often cause >10% price impact; event scheduled.
8/18/2026, 12:00:00 AM
Home Depot Inc. (The) (HD) · Earnings Release
Q2 2026 earnings release and conference call on August 18, 2026. Estimated price impact ~5% as earnings releases typically drive significant volatility; scheduled.
8/18/2026, 12:00:00 AM